Tema Cardiovascular is selling for under 32.33 as of the 28th of November 2024; that is 1.28 percent increase since the beginning of the trading day. The etf's lowest day price was 31.92. Tema Cardiovascular has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Tema Cardiovascular and are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Tema Cardiovascular and [HRTS] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Strategy ETFs. Tema Cardiovascular and currently have in assets under management (AUM). , while the total return for the last year was 18.7%.
Check Tema Cardiovascular Probability Of Bankruptcy
Geographic Allocation (%)
Tema Cardiovascular and Currency Exposure
Tema Cardiovascular and holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Tema Cardiovascular will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Tema Cardiovascular and.
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tema Cardiovascular. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether Tema Cardiovascular and is a strong investment it is important to analyze Tema Cardiovascular's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tema Cardiovascular's future performance. For an informed investment choice regarding Tema Etf, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tema Cardiovascular and. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
The market value of Tema Cardiovascular and is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Cardiovascular's value that differs from its market value or its book value, called intrinsic value, which is Tema Cardiovascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Cardiovascular's market value can be influenced by many factors that don't directly affect Tema Cardiovascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Cardiovascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Cardiovascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Cardiovascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.